Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Trade-Ideas LLC identified Taubman Centers ( TCO) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate. In addition to specific proprietary factors, Trade-Ideas identified Taubman Centers as such a stock due to the following factors:
- TCO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $43.7 million.
- TCO has traded 62,088 shares today.
- TCO traded in a range 260% of the normal price range with a price range of $2.68.
- TCO traded above its daily resistance level (quality: 3 days, meaning that the stock is crossing a resistance level set by the last 3 calendar days. The resistance price is defined by the Price - $0.01 at the time of the signal).
Stocks matching the 'Barbarian at the Gate' criteria are worthwhile stocks to watch for a variety of factors including historical back testing and volatility. Trade-Ideas targets these opportunities because the stock is exhibiting an unusual behavior while displaying positive price action. In this case, the stock crossed an important inflection point; namely, 'resistance' while at the same time the range of the stock's movement in price is more than twice its normal size. This large range foreshadows a possible continuation as the stock moves higher. EXCLUSIVE OFFER: Get the inside scoop on opportunities in TCO with the Ticky from Trade-Ideas. See the FREE profile for TCO NOW at Trade-Ideas More details on TCO: Taubman Centers, Inc. operates as a real estate investment trust. As of June 30, 2005, the company owned a 63% managing general partner's interest in The Taubman Realty Group Limited Partnership (the operating partnership). The stock currently has a dividend yield of 3.2%. TCO has a PE ratio of 41.1. Currently there are no analysts that rate Taubman Centers a buy, no analysts rate it a sell, and 9 rate it a hold. The average volume for Taubman Centers has been 533,200 shares per day over the past 30 days. Taubman Centers has a market cap of $4.0 billion and is part of the financial sector and real estate industry. The stock has a beta of 1.13 and a short float of 2.3% with 1.99 days to cover. Shares are up 0.3% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates Taubman Centers as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Highlights from the ratings report include:
- TAUBMAN CENTERS INC has improved earnings per share by 8.6% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, TAUBMAN CENTERS INC increased its bottom line by earning $1.36 versus $1.28 in the prior year. This year, the market expects an improvement in earnings ($1.65 versus $1.36).
- Despite its growing revenue, the company underperformed as compared with the industry average of 9.6%. Since the same quarter one year prior, revenues slightly increased by 2.0%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
- 37.67% is the gross profit margin for TAUBMAN CENTERS INC which we consider to be strong. Regardless of TCO's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 14.68% trails the industry average.
- TCO has underperformed the S&P 500 Index, declining 18.03% from its price level of one year ago. Looking ahead, although the push and pull of the overall market trend could certainly make a critical difference, we do not see any strong reason stemming from the company's fundamentals that would cause a continuation of last year's decline. In fact, the stock is now selling for less than others in its industry in relation to its current earnings.
- Net operating cash flow has declined marginally to $97.76 million or 1.61% when compared to the same quarter last year. In addition, when comparing the cash generation rate to the industry average, the firm's growth is significantly lower.
- You can view the full Taubman Centers Ratings Report.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.